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ERp57 is a lumenal protein of the endoplasmic reticulum (ER) and a member of the protein
disulfide isomerase (PDI) family. In contrast to archetypal PDI, ERp57 interacts specifically with
newly synthesized glycoproteins. In this study we demonstrate that ERp57 forms discrete com-
plexes with the ER lectins, calnexin and calreticulin. Specific ERp57/calreticulin complexes exist
in canine pancreatic microsomes, as demonstrated by SDS-PAGE after cross-linking, and by native
electrophoresis in the absence of cross-linking. After in vitro translation and import into micro-
somes, radiolabeled ERp57 can be cross-linked to endogenous calreticulin and calnexin while
radiolabeled PDI cannot. Likewise, radiolabeled calreticulin is cross-linked to endogenous ERp57
but not PDI. Similar results were obtained in Lec23 cells, which lack the glucosidase I necessary
to produce glycoprotein substrates capable of binding to calnexin and calreticulin. This observa-
tion indicates that ERp57 interacts with both of the ER lectins in the absence of their glycoprotein
substrate. This result was confirmed by a specific interaction between in vitro synthesized
calreticulin and ERp57 prepared in solution in the absence of other ER components. We conclude
that ERp57 forms complexes with both calnexin and calreticulin and propose that it is these
complexes that can specifically modulate glycoprotein folding within the ER lumen.
INTRODUCTION
In order to enter the secretory pathway, proteins are cotrans-
lationally translocated across the membrane of the endoplas-
mic reticulum (ER) as extended polypeptide chains. Upon
entering the lumen of the ER the proteins begin to fold,
normally with the assistance of molecular chaperones and
other folding factors (Gething and Sambrook, 1992). Cal-
nexin, an integral membrane protein, and calreticulin, a
soluble lumenal protein, are two such molecular chaperones
believed to be involved in this process (reviewed in by
Helenius et al., 1997; Trombetta and Helenius, 1998). They
share regions of high sequence identity and have similar
binding activities, associating transiently with many glyco-
proteins being synthesized within the ER (Ou et al., 1993;
Peterson et al., 1995; Helenius et al., 1997).
Calnexin and calreticulin predominantly act as lectins rec-
ognizing proteins carrying one or more monoglucosylated
oligosaccharide side chains regardless of the conformation
of the polypeptide (Rodan et al., 1996; Zapun et al., 1997). The
carbohydrate structure, GlcNAc2Man7–9Glc1, is generated
from the initial N-linked glycan, GlcNAc2Man9Glc3, by the
action of glucosidases I and II. The presence of monoglu-
cosylated oligosaccharides, and hence calnexin and calreti-
culin binding, is determined by two enzymes. Glucosidase II
removes the final glucose residue generating a deglucosy-
lated side chain, and UDP glucose:glycoprotein glucosyl
transferase (UGGT) can add a single glucose residue back
onto this structure, thus regenerating the monoglucosylated
side chain (Trombetta et al., 1989). Significantly, UGGT rec-
ognizes only incompletely folded glycoproteins as sub-
strates (Trombetta and Parodi, 1992; Sousa and Parodi,
1995). Thus, UGGT acts as a folding sensor, detecting non-
native glycoproteins and reglucosylating them, thereby al-
lowing further rounds of binding to calnexin and calreticulin
(Hammond and Helenius, 1994; Peterson et al., 1995; van
Leeuwen and Kearse, 1996; Helenius et al., 1997).
If calnexin and calreticulin act principally as lectins, then
additional ER components may be required to directly in-
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fluence protein folding during the calnexin/calreticulin cy-
cle. The principal candidate for this role is ERp57. ERp57
(also known as ERp61, ER-60, GRP58, PDI-Q2, and HIP 70)
is a member of the protein disulfide isomerase (PDI) family
which, in addition to archetypal PDI, also includes ERp72
(CaBP2), P5 (CaBP1) (Freedman et al., 1994; Holtzman, 1997)
and the pancreas-specific PDIp (Desilva et al., 1997; Volkmer
et al., 1997). ERp57 contains two “thioredoxin motifs” which
in PDI constitute the thiol/disulfide oxidoreductase active
sites (Freedman et al., 1994). A PDI-like thiol-dependent
reductase activity for ERp57 has been demonstrated in vitro
by several groups (Srivastava et al., 1993; Bourdi et al., 1995;
Hirano et al., 1995), indicating that ERp57 may influence
protein folding. ERp57 has also been proposed to be a car-
nitine palmitoyl transferase (Murthy and Pande, 1994), a
cysteine protease (Urade and Kito, 1992), and a hormone-
induced protein of the brain (Mobbs et al., 1990a,b).
We have previously shown that the thiol-dependent re-
ductase, ERp57, interacts specifically with glycosylated se-
cretory and membrane proteins imported into canine pan-
creatic microsomes (Elliott et al., 1997; Oliver et al., 1997) and
semipermeabilized mammalian cells (Van der Wal et al.,
1998). Like the interactions of calnexin and calreticulin, the
interactions of ERp57 with glycoproteins required glucose
trimming for both binding and release. We concluded that
ERp57 interacted with glycoproteins in tandem with caln-
exin or calreticulin, most likely as a complex.
Other workers have also provided evidence that ERp57 is
an important factor in glycoprotein folding. Zapun et al.
(1998) found that when unfolded monoglucosylated ribonu-
clease B was bound to a soluble version of calnexin, missing
the transmembrane and cytosolic portions, its folding was
greatly enhanced by the presence of ERp57, but not PDI.
This work demonstrated the ability of ERp57 to catalyze the
formation of disulfide bonds in a glycoprotein bound to
calnexin. Several groups have demonstrated the presence of
ERp57, in addition to calnexin and calreticulin, during the
assembly of the MHC class I complex (Hughes and Cress-
well, 1998; Lindquist et al., 1998; Morrice and Powis, 1998).
In this study, we set out to investigate more directly the
interactions of ERp57, calnexin, calreticulin, and PDI in a
variety of systems.
MATERIALS AND METHODS
Restriction enzymes were purchased from New England Biolabs
(Herts, UK). T7 and T3 RNA polymerases, transcription buffers,
rabbit reticulocyte lysate, and Flexi-lysate were supplied by Pro-
mega (Southampton, UK). Bismaleimidohexane (BMH) was from
Pierce and Warriner (Warrington, UK). Polyclonal rabbit anti-calre-
ticulin serum used for blotting was raised against mature human
calreticulin (Roderick et al., 1997). Anti-calreticulin serum for im-
munoprecipitation was from Affinity BioReagents (Cambridge Bio-
science, Cambridge, UK); anti-calnexin was a gift from Dr. Ari
Helenius (Yale University, New Haven, CT); anti-ERp57 was a gift
from Dr. Tom Wileman (Institute for Animal Health, Woking, UK);
anti-PDI was kindly provided by Dr. Neil Bulleid (University of
Manchester, Manchester, UK). Chinese hamster ovary and Lec23
cell lines were a gift from Dr. P. Stanley (Albert Einstein College of
Medicine, New York, NY). Protein A-Sepharose was supplied by
Zymed (Cambridge Bioscience, Cambridge, UK). l-[35S]methionine
and the Western blot reagent (Renaissance) were purchased from
New England Nuclear DuPont (Stevenage, UK). Digitonin was sup-
plied by Calbiochem (Nottingham, UK). All other chemicals were
purchased from Sigma (Dorset, UK) or BDH-Merck (Dorset, UK).
Constructs
Human calreticulin cDNA was isolated by RT-PCR (Roderick et al.,
1997) and cloned into pCR3 (Invitrogen, Leek, The Netherlands).
Human PDI cDNA in pBluescript SK(2) was kindly provided by Dr.
Neil Bulleid (University of Manchester). Human ERp57 (ERp60) cDNA
in pVL1392 was a kind gift from Dr. Kari Kivirikko (Koivunen et al.,
1996). The ERp57 construct was removed from this vector by EagI and
EcoRI digestion and ligated into pBluescript II KS.
All plasmids were linearized at convenient restriction sites after
the stop codon of the cDNA sequence. Transcriptions were carried
out with T7 (calreticulin and ERp57) or T3 (PDI) RNA polymerase
using a standard transcription reaction as described by the manu-
facturer (Promega). The RNA obtained was used for translation
reactions.
Native Gels
The blue native gel electrophoresis method of Schagger and von
Jagow was adapted for analysis of the lumenal components of the
ER (Schagger and von Jagow, 1991; Schagger et al., 1994). Canine
pancreatic microsomes in 750 mM aminocaproic acid, 50 mM Bis-
Tris, pH 7, were treated with 0.5% saponin for 30 min at 4°C
followed by centrifugation at 100,000 3 g for 20 min at 4°C. Sample
buffer (final concentration: 15% glycerol, 50 mM BisTris, pH 7) was
added to the supernatant, comprising the lumenal contents of the
microsomes. The samples were then electrophoresed on 6–16%
native polyacrylamide gel with 50 mM BisTris, pH 7, as the anode
buffer and 50 mM Tricine, 15 mM BisTris, pH 7, as the cathode
buffer at 150 V overnight at 4°C. The resolved proteins were then
transferred to PVDF by blotting and probed for the presence of
ERp57, calreticulin, and PDI.
Translation and Cross-Linking
Calreticulin, ERp57, and PDI were translated in the presence or in
the absence of canine pancreatic microsomes or semipermeabilized
mammalian cells as indicated. A standard rabbit reticulocyte lysate
translation system was used for translation in the presence of a
source of ER membranes (i.e., microsomes or semipermeabilized
cells), whereas a Flexi-lysate rabbit reticulocyte translation system
was used for translation in the absence of ER membranes.
Translations in the presence of microsomes were carried out in a
standard rabbit reticulocyte lysate translation system (Promega) for
45 min at 30°C. Subsequently, 5 mM 7-methylguanosine 59-mono-
phosphate was added to inhibit initiation, and 5 min later transla-
tion was terminated by the addition of 2.5 mM cycloheximide. The
microsomal fraction was isolated by centrifugation through a high-
salt/sucrose cushion (250 mM sucrose, 500 mM potassium acetate,
5 mM magnesium acetate, 50 mM HEPES-KOH, pH 7.9) for 10 min
at 130,000 3 g. The microsomal pellet was then resuspended in a
low- salt/sucrose buffer (250 mM sucrose, 100 mM potassium ace-
tate, 5 mM magnesium acetate, 50 mM HEPES-KOH, pH 7.9), the
cross-linking reagent bismaleimidohexane (BMH) was added to a
final concentration of 0.5 mM, and the samples were incubated at
30°C for 10 min. BMH cross-links interacting proteins via the -SH
groups of free cysteine residues. The cross-linking reaction was
quenched by the addition of 0.1 volumes of 100 mM 2-mercapto-
ethanol, and the samples were left for 10 min on ice.
Semipermeabilized parental Chinese hamster ovary (CHO) cells
and Lec23 CHO cells were prepared as previously described (Van
der Wal et al., 1998). After permeabilization of the cells with digi-
tonin at 20 mg/ml and removal of endogenous RNA by micrococcal
nuclease treatment, reticulocyte lysate translations were carried out
as described above for microsomes.
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Translations in the absence of microsomes or semipermeabilized
cells were carried out using a Flexi-lysate translation system (Pro-
mega). Translations were incubated for 60 min at 30°C in the pres-
ence of either [35S]methionine or 1 mM unlabeled methionine. These
incubations were similar to the standard reticulocyte lysate transla-
tions described above, except that both reducing agents (DTT) and
a source of ER (canine pancreatic microsomes or semipermeabilized
cells) were absent. Additionally, after incubation with 7-methyl-
guanosine 59-monophosphate, 1 mM puromycin was added for 5
min before cycloheximide treatment to ensure that all nascent
chains were released from ribosomes in addition to inhibiting all
protein synthesis. Translation products were mixed as indicated in
the figure legend and incubated for 15 min at 30°C. BMH was added
to 0.5 mM, and the samples were incubated for 10 min at 30°C and
then quenched as described above.
Immunoprecipitation
All samples were subjected to immunoprecipitation after SDS de-
naturation. SDS was added to 1% and the samples were heated at
95°C for 5 min. At least 4 volumes of IP buffer (10 mM Tris-HCl, pH
7.6, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100) were added.
Methionine and PMSF were added to 1 mM each, and the samples
were incubated on ice for 15–30 min, followed by centrifugation at
16,000 3 g for 5 min. Specific antisera were added to aliquots of the
resulting supernatant and the aliquots were then incubated over-
night at 4°C with mixing. Protein A-Sepharose, which had been
preincubated with 20% BSA for 30 min and then washed 5 times
with IP buffer, was added to the samples, and the incubation was
continued for 2 h. The protein A-Sepharose–bound material was
then isolated by centrifugation at 16,000 3 g for 1 min, washed five
times with IP buffer, and then heated at 95°C for 5 min in SDS-PAGE
sample buffer.
Sample Analysis
The samples were subjected to SDS-PAGE on 8% or 12% gels as
indicated and subjected to autoradiography or phosphorimaging
using a Fujix Bas 2000 bioimager (Fuji, Kanagawa, Japan). Quanti-
tation was carried out using the Fujix Bas 2000 analysis software.
RESULTS
Cross-Linking in Microsomes
We have previously demonstrated that ERp57, a member of
the PDI family of proteins, interacts specifically with both
secretory and membrane glycoproteins in association with
the ER lectins, calnexin and calreticulin (Elliott et al., 1997;
Oliver et al., 1997). In this study we set out to analyze the
putative interactions of ERp57 with calnexin and calreticulin
directly.
We first investigated the interactions between the endog-
enous calnexin, calreticulin, ERp57, and PDI present in ER-
derived microsomes. Canine pancreatic microsomes were
treated with the bifunctional cysteine-specific cross-linking
reagent bismaleimidohexane (BMH) or a solvent control
(DMSO), and the products were separated by SDS-PAGE.
Antibodies to calreticulin, ERp57, calnexin, and PDI were
then used to identify these proteins and their cross-linking
products after Western blotting. Analysis of the control-
treated microsomes with calreticulin-specific antisera re-
vealed a single band at 60 kDa as expected (the predicted
molecular mass of calreticulin is 46 kDa; however, on SDS
PAGE it usually has an apparent molecular mass of 60 kDa;
see Figure 1, lane 1). After cross-linking, two major high-
molecular-mass cross-linking products were observed at
;120–130 kDa, indicating that calreticulin was cross-linked
to an ER protein(s) of ;60–70 kDa (Figure 1, lane 2, indi-
cated by arrows).
Blotting with ERp57 antisera reveals microsomal ERp57 to
be ;57 kDa (Figure 1, lane 3). After cross-linking, several
high-molecular-weight products were observed, most strik-
ingly two prominent bands with identical mobility to the
cross-linking products detected by the calreticulin antisera
(Figure 1, lane 4, indicated by arrows). We presume that
these products represent ERp57–calreticulin adducts
formed between the endogenous proteins present in the ER
lumen. The observation of two products with different mo-
bilities probably reflects cross-linking between different cys-
teines present within the two proteins.
No obvious cross-linking products were observed with
the antisera specific for calnexin, and only microsomal cal-
nexin of ;90 kDa was seen (Figure 1, lanes 5 and 6). PDI,
which migrates at 54–57 kDa (Figure 1, lanes 7 and 8),
appears to cross-link weakly to several higher molecular
weight ER components, but no products comparable to
those obtained with ERp57 were observed (Figure 1, lane 8).
The small increases in the apparent molecular masses of
ERp57 and PDI after treatment with BMH (Figure 1, c.f.
lanes 3 and 4, and lanes 7 and 8) probably reflect the mod-
ification of all the available cysteine residues present within
the proteins. In the case of calreticulin, an intrachain cross-
link appears to occur, generating a faster migrating species
(Figure 1, lane 2).
Figure 1. The association of endogenous ER proteins. Canine pan-
creatic microsomes were treated with either DMSO (solvent control,
lanes 1, 3, 5, and 7) or 1 mM BMH (lanes 2, 4, 6, and 8). The samples
were then separated on an 8% SDS polyacrylamide gel and trans-
ferred to nitrocellulose. Antisera to calreticulin (CRT, lanes 1 and 2),
ERp57 (lanes 3 and 4), calnexin (CNX, lanes 5 and 6), and PDI (lanes
7 and 8) were used for immunodetection.
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Native Gel Analysis of ERp57–Calreticulin
Interaction
In order to investigate ERp57–calreticulin complexes in mi-
crosomes in the absence of cross-linking, the lumenal con-
tents of microsomes were separated by native gel electro-
phoresis, with the aim of preserving endogenous protein
complexes intact. The lumenal contents were extracted from
pancreatic microsomes by saponin treatment and centrifu-
gation, and, after separation by native gel electrophoresis,
the presence of protein complexes was investigated by im-
munoblotting.
Although the estimation of molecular mass from native
gels is inaccurate, native gel standards were run to provide
some indication of the size of the products. Antisera raised
against calreticulin and PDI both detected major bands at
55–70 kDa, which most likely represent the monomers of
calreticulin and PDI. The major product detected by ERp57
ran as a smear at ;75 kDa. However, after immunodetection
of calreticulin and ERp57, a further band was observed
corresponding to a higher molecular mass product (Figure 2,
lanes 1 and 4, star). No higher molecular mass products
were observed after immunodetection of PDI. The high-
molecular-mass product detected by anti-calreticulin had an
identical mobility to the product detected by the anti-ERp57,
corresponding to ;140 kDa, consistent with it being a cal-
reticulin-ERp57 heterodimer.
When the microsomes were treated with the cross-linking
reagent BMH before the extraction of the lumenal contents
and sample preparation, the results were similar to those
observed after SDS-PAGE (see previous section). Two bands
were observed at ;120–140 kDa in both the anti-calreticulin
(lane 3, circles) and the anti-ERp57 (lane 6, circles) samples.
The upper band of the cross-linked sample (lanes 3 and 6)
ran at an identical mobility to the 140-kDa product detected
in the untreated samples (lanes 1 and 4, star). Cross-linking
enhanced the amount of calreticulin and ERp57 present in
the complex, implying that, during saponin extraction, cen-
trifugation, and electrophoresis, some of the complex disso-
ciates in the untreated sample. Heating the sample to 95°C
for 5 min before electrophoresis destroyed the association of
ERp57 with calreticulin, and only the monomers were de-
tected. Thus the interaction between ERp57 and calreticulin
detected by cross-linking represents a genuine protein com-
plex that can also be detected in the absence of cross-linking
after native electrophoresis.
Cross-Linking of Calreticulin, ERp57, and PDI to
Endogenous Microsomal Proteins
The above data indicated that calreticulin and ERp57 inter-
act within the lumen of pancreatic microsomes. In order to
investigate this possibility further, the cDNA constructs for
calreticulin, ERp57, and PDI were utilized. RNA was made
from the cDNA constructs, enabling the in vitro translation
of 35S-labeled calreticulin, ERp57, and PDI. By including
microsomes in the translation reaction, these three proteins
were translocated across the microsomal membrane with
concomitant signal sequence cleavage (demonstrated by re-
sistance to proteinase K digestion [our unpublished obser-
vations]). Cross-linking studies were then carried out to
determine whether these 35S-labeled proteins interacted
with any endogenous microsomal proteins.
Discrete cross-linking products were obtained after the
addition of BMH to microsomes into which radiolabeled
calreticulin (Figure 3, lane 2 compared with lane 1) or ERp57
(Figure 3, lane 8 compared with lane 7) had been imported.
These cross-linking products were identified by immuno-
precipitation, and the major cross-linking partner of 35S-
labeled calreticulin was found to be microsomal ERp57 (Fig-
ure 3, lane 5). The same interaction was reproduced when
35S-labeled ERp57 was imported into microsomes and found
to be cross-linked to endogenous calreticulin (Figure 3, lane
11). Three identical major cross-linking products between
calreticulin and ERp57 were observed (Figure 3, lanes 5 and
11, circles), most likely due to cross-linking between differ-
ent cysteine residues within the two proteins. In addition to
cross-linking endogenous calreticulin, 35S-labeled ERp57
was also found to cross-link to microsomal calnexin (Figure
3, lane 10, star). In contrast, 35S-labeled calreticulin was not
cross-linked to calnexin (Figure 3, lane 4). The specificity of
the ERp57/calreticulin and ERp57/calnexin cross-linking
products was further underlined by our finding that 35S-
labeled PDI did not form any similar cross-linking products
(Figure 3, c.f. lanes 13 and 14), and that no PDI cross-linking
products were immunoprecipitated with antisera recogniz-
ing calnexin, calreticulin, or ERp57 (Figure 3, lanes 16–18).
These results indicated that discrete complexes between
calnexin and ERp57, and calreticulin and ERp57, could be
reconstituted by importing in vitro translated, 35S-labeled
calreticulin or ERp57 into microsomes. None of the newly
synthesized proteins (i.e., calreticulin, ERp57, and PDI) are
N-glycosylated (our unpublished observations), ruling out
any possibility that the interactions observed were due to
the ER lectins, calnexin and calreticulin, binding to a glyco-
protein substrate. Significantly, the efficiency of cross-link-
ing observed in these experiments was also substantially
higher than that which we typically observe for chaperone–
substrate interactions (#30% vs. ,5%, respectively).
Figure 2. Native gel analysis of ER protein complexes. The lume-
nal contents of canine pancreatic microsomes were separated by
blue native gel electrophoresis and then transferred to PVDF. The
proteins were detected by immunoblotting with antisera raised
against calreticulin (CRT, lanes 1–3), ERp57 (lanes 4–6), and PDI
(lanes 7–9). The samples were untreated (lanes 1, 4, and 7); heated to
95°C before electrophoresis (lanes 2, 5 and 8), or treated with 1 mM
BMH before isolation of the lumenal contents (lanes 3, 6, and 9).
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Cross-Linking of Calreticulin, ERp57, and PDI to
Endogenous ER Proteins in Semipermeabilized
Mammalian Cells
In the canine pancreatic microsome system employed thus
far, it was unclear whether the binding of ERp57 to calnexin
and calreticulin required the presence of glucose-trimmed
glycoprotein substrates. In order to address this point, a cell
line that lacks the glucose-trimmed glycoprotein substrates
of these lectins was used. Lec23 cells are derived from CHO
cells, but they lack glucosidase I activity and are unable to
produce monoglucosylated glycoproteins (Ray et al., 1991).
Hence, in Lec23 cells, calnexin and calreticulin do not bind
glycoproteins (Ora and Helenius, 1995; Van der Wal et al.,
1998). In order to employ parental CHO cells and Lec23
CHO cells in in vitro cross-linking experiments, they were
first selectively permeabilized with digitonin to allow the
import of 35S-labeled calreticulin, ERp57, and PDI.
The interactions of the imported radiolabeled components
with endogenous ER proteins in semipermeabilized parental
CHO cells (Figure 4A) and Lec23 CHO cells (Figure 4B) were
detected by cross-linking and were very similar to those
observed for canine pancreatic microsomes (c.f. Figure 3).
Briefly, 35S-labeled calreticulin interacts with endogenous
ERp57 (Figure 4, A and B, lane 5, circles), and 35S-labeled
ERp57 interacts with endogenous calnexin (Figure 4, A and
B, lane 10, star) and calreticulin (Figure 4, A and B, lane 11,
circles). 35S-labeled PDI displays no strong cross-linking
products with endogenous proteins (cf. Figure 4, A and B,
lanes 13 and 14). These results indicate that interaction of
ERp57 with both calnexin and calreticulin does not require
the presence of a glucose-trimmed glycoprotein substrate.
ERp57 Forms a Complex with Calreticulin in the
Absence of Microsomes
The ability to synthesize calreticulin and ERp57 in vitro
enabled us to investigate whether these two proteins could
interact in solution in the absence of any other ER proteins.
ERp57, calreticulin, and PDI were translated in the Flexi-
lysate rabbit reticulocyte translation system supplemented
with either unlabeled methionine or [35S]methionine. By
mixing “cold” (unlabeled) proteins with radiolabeled pro-
teins, we could cross-link interacting components and define
these complexes by immunoprecipitation.
In contrast to the precursors imported into microsomes,
the N-terminal signal sequences were still present on the
resulting polypeptides. However, although the presence of
such signal sequences can slow down the rate of protein
folding, the mature region of the protein frequently attains
an essentially native conformation that is indistinguishable
from that observed after signal sequence cleavage (Park et
al., 1988). Hence, in the case of maltose-binding protein, the
presence of the N-terminal signal sequence does not prevent
the protein binding to its natural ligand, underlining its
ability to fold into a native structure (Park et al., 1988).
Since the translation reactions were incubated for 1 h
before the different ER precursors were combined, it seemed
likely that a substantial amount of the precursor proteins
would fold correctly during this time. Indeed, under the
experimental conditions used, we found that calreticulin
with its N-terminal signal sequence present was able to form
a characteristic intrachain disulfide bond (our unpublished
observations) indicative of correct protein folding (Mat-
suoka et al., 1994; c.f. Hebert et al., 1995).
In addition to major radiolabeled products representing
the full-length proteins with uncleaved signal sequences
(indicated by the arrowheads in Figure 5A–C), several prod-
ucts with slightly different mobilities were also observed
(Figure 5, A and C). These may be the result of premature
chain termination, ribosome stacking, proteolytic cleavage,
or other posttranslational events and are not unusual in such
assays (e.g., Lutcke et al., 1992).
Mixing 35S-calreticulin with unlabeled ERp57 led to an
interaction that could be stabilized by cross-linking, and the
resulting adduct was immunoprecipitated by anti-calreticu-
lin (Figure 5A, lane 6) and anti-ERp57 (Figure 5A, lane 7)
sera. This product was not observed when unlabeled ERp57
was replaced by unlabeled calreticulin or PDI (Figure 5A,
lanes 3 and 11). When the reciprocal experiment was per-
formed, and 35S-ERp57 was mixed with unlabeled calreticu-
lin, a similar product was observed (Figure 5B, lanes 2 and
3). Once again, PDI did not form any cross-linking products
with either calreticulin (Figure 5A, lane 12; Figure 5C, lane 3)
or ERp57 (Figure 5B, lane 12; Figure 5C, lane 8). Since the
cross-linking reactions in these experiments were carried out
Figure 3. Interactions of in vitro synthesized calreticulin, ERp57,
and PDI with the endogenous ER proteins of microsomes. Calreti-
culin (CRT, lanes 1–6), ERp57 (lanes 7–12), and PDI (lanes 13–18)
RNAs were translated in a rabbit reticulocyte lysate system in the
presence of microsomes. After termination of translation, the micro-
somal fraction was isolated and, where indicated, the samples were
treated with the cross-linking reagent BMH. The reaction was
quenched, and the samples denatured with 1% SDS before immu-
noprecipitation with the antisera indicated: CRT, anticalreticulin;
NRS, control nonrelated serum; CNX, anti-calnexin; ERp57, anti-
ERp57; PDI, anti-PDI. The samples were analyzed on an 8% SDS-
polyacrylamide gel. The identity of imported polypeptides with
cleaved signal sequences (indicated by arrows) was confirmed by
protease protection and comparison with unprocessed polypeptides
bearing signal sequences (our unpublished observations).
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in the complete in vitro translation system, and therefore in
the presence of the many cytosolic proteins present in the
reticulocyte lysate, this result indicates that the cross-linking
observed between ERp57 and calreticulin is due to a very
specific protein–protein interaction.
DISCUSSION
The exact nature and importance of the calnexin–calreticulin
pathway during glycoprotein folding and quality control
remain controversial (see Helenius et al., 1997; Trombetta
and Helenius, 1998). The view that calnexin and calreticulin
bind to the carbohydrate moiety of a glycoprotein substrate
as an initial recognition event, and that this enables subse-
quent protein–protein interactions to occur (Arunachalam
and Cresswell, 1995; Ware et al., 1995; Zhang et al., 1995), has
now largely been superseded. There is very good evidence
that calnexin and calreticulin function as lectins and recog-
nize only carbohydrate, and not protein, determinants. Sev-
eral groups have recently demonstrated that calnexin and
calreticulin alone do not distinguish between folded and
unfolded polypeptides and will bind to a substrate as long
as it is monoglucosylated (Rodan et al., 1996; Allen and
Bulleid, 1997; Zapun et al., 1997). These data also suggest
that calnexin and calreticulin do not influence glycoprotein
folding directly.
While calnexin and calreticulin may not recognize protein
determinants directly, it is possible that these molecules
recruit other ER components that do exert a direct effect on
protein folding. The best candidate for such a component is
ERp57, a member of the PDI family of proteins. PDI-like
proteins contain two (PDI, ERp57, P5, PDIp), or three
(ERp72) copies of the sequence motif -Cys-Gly-His-Cys-. In
PDI this motif is the active site for disulfide formation and
isomerization activities (Vuori et al., 1992; LaMantia and
Lennarz, 1993). ERp57 has been ascribed a variety of names
and functions, and elucidating its role in vivo has proved
complex (see Elliott et al. [1997] and references therein).
Evidence that ERp57 can interact with newly synthesized
glycoproteins originated from a study of the biosynthesis of
the Glut 1 glucose transporter (Oliver et al., 1996). A 60-kDa
ER lumenal protein was found to interact with calnexin and
its glycoprotein substrate Glut 1. After observing a similar
60- kDa protein associated with nascent secretory glycopro-
teins, we were able to identify it as ERp57 (Oliver et al.,
1997). Subsequently, ERp57 was also shown to associate
with the membrane protein glycophorin C and was formally
identified as a cross-linking partner of Glut 1 (Elliott et al.,
1997). Throughout these studies it was striking that the
substrate-binding properties of ERp57 mimicked those of
calnexin and calreticulin, i.e., both glycosylation and glucose
trimming were required for binding to occur. In addition,
ERp57-glycoprotein cross-linking products were coimmuno-
precipitated with calnexin and calreticulin if the samples
were not first denatured by heating with SDS. These find-
ings suggested that ERp57 bound to nascent glycoproteins
Figure 4. Interactions of in vitro synthesized calreticulin, ERp57, and PDI with the endogenous ER proteins of semipermeabilized cells.
Parental CHO cells (panel A) and glucosidase I-deficient Lec23 CHO cells (panel B) were selectively permeabilized with digitonin.
Calreticulin (CRT, lanes 1–6), ERp57 (lanes 7–12), and PDI (lanes 13–18) RNAs were translated in a rabbit reticulocyte lysate system in the
presence of the semipermeabilized mammalian cells. After termination of translation, the cells were washed and, where indicated, the
samples were treated with the cross-linking reagent BMH. The samples were quenched and denatured with 1% SDS before immunopre-
cipitation with the antisera indicated: CRT, anti-calreticulin; NRS, control nonrelated serum; CNX, anti-calnexin; ERp57, anti-ERp57; PDI,
anti-PDI. The samples were analyzed on an 8% SDS-polyacrylamide gel.
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as part of discrete complexes formed with both calnexin and
calreticulin (Elliott et al., 1997; Oliver et al., 1997; Van der Wal
et al., 1998).
In order to understand better the relationship between
ERp57 and the ER lectins, calnexin and calreticulin, we have
studied their interactions with one another directly. When
the interactions between endogenous ER lumenal proteins
were stabilized by cross-linking, before SDS-PAGE and im-
munoblotting, evidence for specific ERp57–calreticulin ad-
ducts was obtained. Likewise, when the soluble components
present inside ER microsomes were separated by native gel
electrophoresis, an ERp57/calreticulin complex could still
be identified in the absence of any cross-linking. This con-
firmed the presence of ERp57/ER lectin complexes within
ER-derived pancreatic microsomes.
To increase the sensitivity of our assay, we next synthe-
sized radiolabeled calreticulin, ERp57, and PDI in vitro,
imported these 35S-labeled proteins into microsomes, and
Figure 5. Interactions between in vitro translated calreticulin,
ERp57, and PDI in solution. The products of a translation reaction
carried out in the presence of [35S]methionine were mixed with the
products of a translation reaction carried out with unlabeled methi-
onine, and the resulting protein complexes were cross-linked with
BMH. 35S-labeled calreticulin (panel A), ERp57 (panel B), and PDI
(panel C) were mixed with unlabeled calreticulin (CRT, lanes 1–4),
ERp57 (lanes 5–8), and PDI (lanes 9–12). After cross-linking and
SDS denaturation, immunoprecipitation was carried out with the
antisera indicated (see Figure 3 for key). The samples were analyzed
on an 8% SDS-polyacrylamide gel. The identity of full-length pre-
cursor proteins (i.e., with signal sequences; indicated by arrow-
heads) was experimentally confirmed (our unpublished observa-
tions).
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studied their interactions with endogenous ER lumenal
components. Very strong cross-linking of labeled calreticu-
lin to endogenous ERp57 was observed, and in the converse
experiment labeled ERp57 was found to cross-link strongly
to endogenous calreticulin. In addition, labeled ERp57 was
cross-linked to endogenous calnexin. Thus, it was possible to
form complexes of ERp57 with either calnexin or calreticulin
in vitro. Since ERp57 is not glycosylated, these complexes
are clearly not the result of “typical” interactions between
calnexin/calreticulin and a glycoprotein substrate.
As ERp57 is a member of the PDI family of proteins, we
chose archetypal PDI as a control for these experiments.
Archetypal PDI has 29% sequence identity and 56% se-
quence similarity with ERp57 (Koivunen et al., 1996). The
cross-linking experiments employed a homobifunctional re-
agent, BMH, which specifically cross-links proteins to one
another via their cysteine residues. Both mature proteins
contain six cysteine residues, while PDI contains an addi-
tional cysteine in the signal sequence. Furthermore, PDI had
successfully been cross-linked to a cys-containing mutant of
glycophorin C (Elliott et al., 1997) and to procollagen chains
(Wilson et al., 1998) using BMH. Hence, although clearly
capable of BMH-dependent cross-linking, no adducts of PDI
with calnexin or calreticulin were observed with this re-
agent. In addition, no complexes were detected between
calreticulin and PDI after native gel electrophoresis.
The cross-linking experiments were repeated substituting
semipermeabilized mammalian cells for microsomes. Once
again, complexes were observed between ERp57 and calre-
ticulin or calnexin, both in parental CHO cells capable of
typical glycoprotein processing, and in Lec23 CHO cells in
which glucosidase I activity is defective. Calnexin and cal-
reticulin do not bind to glycoproteins in Lec23 cells (Ora and
Helenius, 1995; Van der Wal et al., 1998), and hence we could
conclude that ERp57–calreticulin and ERp57–calnexin com-
plexes are formed in the absence of glycoprotein substrates
for the ER lectins. This observation was verified by showing
that ERp57 could interact with calreticulin in solution. The
products of two separate in vitro translation reactions were
simply mixed, and the ability of the two translation products
to interact with one another was determined. In these ex-
periments both proteins are present at a much lower effec-
tive concentration than inside the ER lumen, and no mono-
glucosylated glycoprotein substrates would be present.
Remarkably, efficient and specific cross-linking of ERp57 to
calreticulin was observed in this system.
We conclude that the ERp57 present in the ER lumen
normally functions as a subunit of discrete complexes
formed with calreticulin and calnexin, and that the forma-
tion of these complexes is not dependent upon the presence
of glycoprotein substrates. These data add substantial
weight to our original proposal that ERp57 functions in
combination with calnexin or calreticulin in order to modu-
late glycoprotein folding within the ER lumen (Elliott et al.,
1997; Oliver et al., 1997). We have now shown that ERp57
forms discrete, stable complexes with both calnexin and
calreticulin.
Our data are in good agreement with the recent study of
Corbett et al. (1999) which showed that purified recombinant
calreticulin and ERp57 interact specifically in solution. Our
current study shows that this interaction reflects the situa-
tion occurring inside an intact ER. This may be contrasted
with the previously reported interaction between calreticu-
lin and PDI (Baksh et al., 1995). We detect no such interaction
when using canine pancreatic microsomes, semi-intact
mammalian cells, or mixing in vitro translation products. It
has now been shown that calreticulin associates with PDI
only at very low Ca21 concentrations, i.e., below 100 mM
(Corbett et al., 1999). The steady state Ca21 concentration in
the ER lumen is reported to be 500–800 mM, and this re-
duces to 200–300 mM after Ca21 release in response to 10
mM histamine (Alonso et al., 1999). Our results were ob-
tained using intact ER-derived microsomes and semi-intact
mammalian cells, and they underline the fact that, under the
conditions observed in vivo (Alonso et al., 1999), ERp57
forms a specific complex with the ER lectins, calnexin and
Figure 6. A proposed model of
glycoprotein folding. Calreticu-
lin (and calnexin, its integral
membrane protein homologue;
not shown) acts as a lectin by
binding to monoglucosylated
oligosaccharide chains present
on newly synthesized glycop-
roteins. By virtue of its associ-
ation with calreticulin, ERp57
is brought into contact with
the glycoprotein. ERp57 mod-
ulates the folding of the glyco-
protein, illustrated here as di-
sulfide bond formation, but
possibly by other mechanisms.
The glycoprotein is released
from calreticulin upon glucose
trimming by glucosidase II. If
the folding has been successful,
the native glycoprotein is free to
continue along the secretory
pathway. If the glycoprotein is
incompletely folded, the folding sensor UDP-glucose:glycoprotein glucosyl transferase (UGGT) adds back a single glucose residue, and
the glycoprotein undergoes another round of lectin binding.
J.D. Oliver et al.
Molecular Biology of the Cell2580
calreticulin, while we find no evidence that PDI is asso-
ciated with these components. The very low Ca21 concen-
tration needed to observe an interaction between PDI and
calreticulin (Corbett et al., 1999) would require an almost
complete emptying of the ER calcium store such as that
observed in response to treatment with 50 mM caffeine
(Alonso et al., 1999).
We propose that ERp57 is recruited to interact with newly
synthesized, incompletely folded, glycoproteins via its asso-
ciation with the lectins, calreticulin and calnexin. Thus, the
perturbation of glycoprotein folding that results from pre-
venting calnexin and calreticulin binding (see Helenius et al.
[1997] and references therein) most likely results from inter-
fering with ERp57 function. Once exposed to a newly syn-
thesized glycoprotein, ERp57 may function as a glycopro-
tein-specific thiol/disulfide oxidoreductase (see Figure 6)
and thereby have a direct influence on protein folding.
The initial studies of ERp57 thiol-reductase activity (Sriv-
astava et al., 1993; Bourdi et al., 1995; Hirano et al., 1995) were
all carried out in the absence of any ER lectins and used a
nonglycosylated precursor (insulin). Since the results de-
scribed above and our previous work (Elliott et al., 1997;
Oliver et al., 1997; Van der Wal et al., 1998) all indicate that
ERp57 functions in combination with calnexin and calreti-
culin to interact exclusively with glycoproteins, these early
studies of ERp57 activity are unlikely to reflect its true
capacity. A recent study by Zapun et al. (1998) has now
addressed these deficiencies. The authors found that the PDI
activity of ERp57 on the refolding of monoglucosylated
ribonuclease B is greatly enhanced by the presence of calre-
ticulin or a soluble form of calnexin. In contrast, the activity
of PDI in the same assay was decreased upon the addition of
ER lectins (Zapun et al., 1998). This observation provides the
first direct evidence that ERp57 can indeed specifically mod-
ulate glycoprotein folding in combination with the ER lec-
tins, calnexin and calreticulin (c.f. Figure 6). On the basis of
the work presented here, we propose that ERp57 performs
this function as a subunit of discrete, stable protein com-
plexes formed with calnexin and calreticulin. Significantly,
ERp57 also binds to glycoproteins that lack any cysteine
residues (Elliott et al., 1997; Oliver et al., 1997), and that do
not, therefore, require any intramolecular disulfide ex-
change. Thus, it remains possible that, like PDI (Freedman et
al., 1994; Kemmink et al., 1997; Yao et al., 1997; Wilson et al.,
1998), ERp57 may also play a more general role as a molec-
ular chaperone within the ER lumen.
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